{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:37:21Z","timestamp":1746319041919,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00105-019-4359-y","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T14:47:23Z","timestamp":1548773243000},"page":"363-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Eruptive Epidermoidzysten nach Imiquimod-Therapie eines rezidivierenden Basalzellkarzinoms","Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma"],"prefix":"10.1007","volume":"70","author":[{"given":"Nora","family":"Woltsche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"El-Shabrawi-Caelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Deinlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romana","family":"Kupsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Gschwandtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Hofmann-Wellenhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"4359_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ijd.13235","volume":"55","author":"E Hanna","year":"2016","unstructured":"Hanna E, Abadi R, Abbas O (2016) Imiquimod in dermatology: An overview. Int J Dermatol 55:831\u2013844","journal-title":"Int J Dermatol"},{"key":"4359_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2340\/00015555-2464","volume":"97","author":"M Urech","year":"2017","unstructured":"Urech M, Kyrgidis A, Argenziano G et\u00a0al (2017) Dermoscopic ulceration is a\u00a0predictor of basal cell carcinoma response to Imiquimod: A retrospective study. Acta Derm Venereol 97:117\u2013119","journal-title":"Acta Derm Venereol"},{"key":"4359_CR3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1684\/ejd.2012.1771","volume":"22","author":"D Tiodorovic-Zivkovic","year":"2012","unstructured":"Tiodorovic-Zivkovic D, Zalaudek I, Longo C et al (2012) Successful treatment of two invasive squamous cell carcinomas with topical 5\u202f% imiquimod cream in elderly patients. Eur J Dermatol 22:579\u2013580","journal-title":"Eur J Dermatol"},{"key":"4359_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ajd.12151","volume":"56","author":"A Drummond","year":"2015","unstructured":"Drummond A, Pichler J, Argenziano G et\u00a0al (2015) Lichen planopilaris after imiquimod 5\u202f% cream for multiple BCC in basal cell naevus syndrome. Australas J Dermatol 56:105\u2013107","journal-title":"Australas J Dermatol"},{"key":"4359_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000107630","volume":"215","author":"MR Nasca","year":"2007","unstructured":"Nasca MR, De Pasquale R, Micali G (2007) Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod. Dermatology 215:352\u2013353","journal-title":"Dermatology"},{"key":"4359_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00042728-200507000-00011","volume":"31","author":"CL Marty","year":"2005","unstructured":"Marty CL, Randle HW, Walsh JS (2005) Eruptive epidermoid cysts resulting from treatment with imiquimod. Dermatol Surg 31:780\u2013783","journal-title":"Dermatol Surg"},{"key":"4359_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.annder.2016.09.042","volume":"144","author":"A-S Dillies","year":"2017","unstructured":"Dillies A\u2011S, Gras-Champel V, Fraitag-Spinner S et al (2017) \u00c9ruption de kystes \u00e9pidermiques apr\u00e8s application d\u2019imiquimod topique. Ann Dermatol Venereol 144:212\u2013215","journal-title":"Ann Dermatol Venereol"},{"key":"4359_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/09546630802441226","volume":"20","author":"L Diluvio","year":"2009","unstructured":"Diluvio L, Campione E, Patern\u00f2 EJ et\u00a0al (2009) Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face. J\u00a0Dermatolog Treat 20:124\u2013129","journal-title":"J Dermatolog Treat"},{"issue":"Suppl 2","key":"4359_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/SAP.0000000000000463","volume":"74","author":"C-J Feng","year":"2015","unstructured":"Feng C\u2011J, Ma H (2015) Treatment of epidermal cysts with erbium: YAG laser fenestration: An alternative to surgical intervention. Ann Plast Surg 74(Suppl 2):89\u201392","journal-title":"Ann Plast Surg"},{"key":"4359_CR10","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.jid.2016.06.613","volume":"136","author":"N Amberg","year":"2016","unstructured":"Amberg N, Holcmann M, Stulnig G, Sibilia M (2016) Effects of Imiquimod on hair follicle stem cells and hair cycle progression. J\u00a0Invest Dermatol 136:2140\u20132149","journal-title":"J Invest Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-4359-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T04:22:54Z","timestamp":1606278174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-4359-y"}},"subtitle":["Ein Fallbericht","A case report"],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4359"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-4359-y","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"type":"print","value":"0017-8470"},{"type":"electronic","value":"1432-1173"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"29 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Woltsche, L.\u00a0El-Shabrawi-Caelen, T.\u00a0Deinlein, R.\u00a0Kupsa, M.\u00a0Gschwandtner, R.\u00a0Hofmann-Wellenhof und I.\u00a0Zalaudek geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}